DFB Healthcare Acquisitions, a blank check company backed by life sciences investment firm Deerfield Management, announced terms for its IPO on Friday.
The New York, NY-based company plans to raise $250 million by offering 25 million units at a price of $10. At that price, DFB Healthcare would command a market value of $313 million. Insiders intend to purchase 2.5 million units on the offering.
DFB Healthcare Acquisitions was founded in 2017 and plans to list on the Nasdaq under the symbol DFBH.RC. Goldman Sachs and Deutsche Bank are the joint bookrunners on the deal.
